Taken together, our data supports the notion of an enhancer hijacking event by which TF MNX1 is ectopically activated in the AML cell line GDM-1, and we propose a hematopoietic enhancer, E1, located in AHI1, as being responsible for MNX1 activation. This evidence concerns the gene MNX1 and acute myeloid leukemia.